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Background: Psoriasis is a common inflammatory skin disease with a known genetic component. Our previously
published psoriasis genome-wide association study identified dozens of novel susceptibility loci in Han Chinese.
However, these markers explained only a small fraction of the estimated heritable component of psoriasis. To better
understand the unknown yet likely polygenic architecture in psoriasis, we applied a linear mixed model to quantify
the variation in the liability to psoriasis explained by common genetic markers (minor allele frequency > 0.01) in a
Han Chinese population.
Results: We explored the polygenic genetic architecture of psoriasis using genome-wide association data from
2,271 Han Chinese individuals. We estimated that 34.9% (s.e. = 6.0%, P = 9 × 10-9) of the variation in the liability to
psoriasis is captured by common genotyped and imputed variants. We discuss these results in the context of the
strong association between HLA variants and psoriasis. We also show that the variance explained by each
chromosome is linearly correlated to its length (R2 = 0.27, P=0.01), and quantify the impact of a polygenic effect
on the prediction and diagnosis of psoriasis.
Conclusions: Our results suggest that psoriasis has a substantial polygenic component, which not only has
implications for the development of genetic diagnostics and prognostics for psoriasis, but also suggests that more
individual variants contributing to psoriasis may be detected if sample sizes in future association studies are
increased.
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Genome-wide association studies (GWAS) have achieved a
good deal of success in establishing thousands of individual
SNPs (single nucleotide polymorphisms) associated with
various common diseases and complex traits (http://www.
genome.gov/gwastudies/). However, the SNPs identified in
these studies collectively explain only a small fraction of
the heritable components of these traits as estimated from
twin studies, leading the research community to question
where the remaining heritable component of these traits
resides – a phenomenon and quest commonly referred to* Correspondence: nschork@scripps.edu; ayzxj@vip.sina.com
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unless otherwise stated.as the search for sources of ‘missing heritability’ [1]. Past
work has suggested that a considerable amount of missing
heritability for common diseases and complex traits can be
accounted for by factors not easily detectable with standard
GWAS analysis techniques, such as the contribution of
rare variants, common variants with weak individual ef-
fects, or a combination of the two [2]. In fact, researchers
have explored data analysis techniques designed for the ex-
press purpose of detecting a polygenic effect based on the
assumption that common variants with small effects con-
tribute to common traits [3]. While the effects of the indi-
vidual variants may be too small to detect using traditional
GWAS approaches, the collective or polygenic effect of nu-
merous markers can be pronounced enough to be detected
through these analyses [3-5].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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affects between 0.1 to 5.0% of the population worldwide
based on geographic region [6]. In total, more than 40
susceptibility genes have been identified through GWAS
involving diverse ethnic populations [6-13]. Across these
studies, variants with large effects in the HLA region are
consistently shown to be associated with psoriasis [14].
We have previously published the first psoriasis GWAS in
a Han Chinese population where we identified 11 novel
susceptibility loci [6,11,13]. Consistent with prior evidence
that suggests GWAS identified SNPs have only explained
roughly 20% of the estimated heritability [12], the variants
we identified did not markedly reduce the unexplained
heritability. Therefore, in the present study we directly in-
vestigated the polygenic architecture of psoriasis in the
Han Chinese population. We also set out to determine the
degree to which this polygenic component contributed to
psoriasis susceptibility over-and-above variants in the
HLA region. We leveraged available data analysis tools,
most notably the program GCTA which implements a lin-
ear mixed model to characterize polygenic effects [5], to
estimate the proportion of variation in liability to psoriasis
that can be captured by the collective effect of common
genome-wide markers (i.e., a polygenic effect) in a Han
Chinese sample. We also considered the degree to which
markers on each chromosome contributed to psoriasis
susceptibility [5,15] as well as the ability to differentiate
psoriasis cases and controls on a purely genetic basis if, or




Our study includes 1,139 psoriasis cases and 1,132 healthy
controls from the Han Chinese population. Cases were
positively diagnosed by at least by two dermatologists and
controls had no psoriasis, no familial history of psoriasis,
and no other forms of autoimmune diseases. Written
informed consent was provided by all participants. This
study was approved by the institutional review committee
of the First Affiliated Hospital, Anhui Medical University,
China, according to the Declaration of Helsinki.
Genotyping, imputation and quality control
The samples were genotyped on the Illumina Human610
Quad BeadChip human array as described previously
[13]. Samples were excluded which had call rates less than
0.9 per sample per SNP. Marker preparation and analytical
implementation for imputation were performed as follows:
genetic markers were excluded which demonstrated high
missingness (> 0.05), failed Hardy-Weinberg equilibrium
(P < 0.0005), or had exceedingly rare alternative alleles
(minor allele frequency < 0.005). The remaining genetic
data were pre-phased, and genome-wide imputation wasperformed on the resulting haplotypes using the default
parameters in IMPUTE v2.2.2 [16]. The 1000 Genomes
Phase 1 integrated variant set haplotypes were used as the
reference panel [17]. Genomes were divided into approxi-
mately 5 Mb segments (avoiding chromosome and centro-
mere boundaries) with phasing and imputation calculated
on each. Imputed markers with information values less
than 0.5 were removed from the analysis. GTOOL
v0.7.0 was used to convert imputed genotyped posterior
probabilities into calls. Genotypes were considered
missing if the posterior probability of any genotype was
not greater than 90%. In both genotyped and imputed
datasets, identical quality control procedures were applied
resulting in the exclusion of markers with minor allele fre-
quency < 0.01; call rate < 0.9; and deviation from Hardy-
Weinberg equilibrium in the controls (P < 10-6).
Polygenic inheritance analysis
A genetic similarity matrix was constructed based on pub-
lished methods [16]. Subjects were excluded such that all
pairs had estimated genetic relationship less than 0.025.
This resulted in the exclusion of 11 and 20 samples in the
genotyped and genotyped and imputed datasets, respect-
ively. The proportion of the liability in phenotypic vari-
ance explained by genetic markers was calculated using a
linear mixed model, implementing restricted maximum
likelihood (REML) analysis. Two kinds of analyses (which
we refer to as ‘Separate’ analysis and ‘Joint’ analysis) were
explored in chromosomal and minor allele frequency par-
titioning. In the separate analysis, the genetic relationship
matrix was estimated separately for 22 individual chro-
mosomes and each allele frequency partition. For the
joint analysis, the genetic relationship matrix was built
simultaneously across all chromosomes and SNPs with
diverse MAFs. We considered the prevalence of psoria-
sis in Chinese Han population at 0.47% per previous
reports [18]. Our analyses were performed using the
GCTA software [5]. In all analyses the top 20 principal
components were included as covariates to control for
potential population stratification. Previously identified
genome-wide significant loci were established through
literature review. The start and end position for each
locus was identified according to dbSNP 130. Overlap-
ping regions were merged.
Results
In total, 494,641 genotyped and 5,610,687 imputed
autosomal SNPs passed quality control thresholds (see
Methods). We refer to the genotyped data as set G and
genotyped and imputed data as set G + I (Table 1). Since
polygenic analyses can be framed in a number of differ-
ent contexts, we briefly consider our results in terms of
the total variation attributable to the collective effect of
common variants, the variation attributable to common
Table 1 The comparative result of phenotypic variance explained by common variants
Type of data No. of autosomal SNPs No. of cases No. of controls h2SNP (s.e.) p value
G 494,641 1137 1123 33.2% (7.0%) 3 × 10-6
G + I 5,610,687 1135 1116 34.9% (6.0%) 8 × 10-9
HLA region in G + I 33,190 1135 1116 13.2% (2.0%) <10-9
Reported loci in G + I 77,919 1135 1116 14.1% (1.0%) <10-9
h2SNP: Proportion of Variance in liability to psoriasis vulgaris explained by autosomal SNPs. s.e.: standard error.
Type of Data: G: All Genotyped; G + I: All Genotyped and Imputed; HLA region in G + I : All Genotyped and Imputed data in HLA region; Reported loci in G + I: 12
Reported loci data in Genotyped and Imputed data.
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contribution of lower frequency variants to a polygenic
component, and an assessment of the implications of a
polygenic effect on the diagnosis of psoriasis.
Genomic variation captured by common SNPs
In the G dataset, we estimated 33.2% of variation in li-
ability to psoriasis (h2SNP) was explained by all auto-
somal SNPs (s.e. = 7.0%, P = 3 × 10-6). This value rose
slightly to 34.9% (s.e. = 6.0%, P = 9 × 10-9) in the G + I
dataset (Table 1). In the G + I dataset, we extracted SNPs
in the HLA region (chr6: 29,700 kb-33,300 kb, including
33,190 SNPs), and found that 13.2% (s.e. = 2.0%, P < 10-9)
of phenotypic variance was explained by HLA markers
(Table 1). We then extracted SNPs from 11 other previ-
ously identified susceptibility regions in addition to the
HLA region. Based on genetic similarity quantified by
variants at these 12 loci (77,919 SNPs), we estimated
h2SNP to be 14.1% (s.e. = 1.0%, P < 10
-9) (Table 1).
Partition of genomic variation by chromosome
We partitioned the genomic variation explained a poly-
genic effect of common variants by chromosome in the
G + I dataset through two kinds of analyses. The first,
the ‘separate analysis’ was pursued by fitting a genetic
similarity matrix separately for each autosomal chromo-
some [5]. For the second analysis, the ‘joint analysis’, the
genetic similarity matrices were fit simultaneously for
all 22 autosomal chromosomes. We observed a positive
linear correlation between the estimates of variance ex-
plained by each chromosome and the relative length of
the chromosome in both analyses (R2sep = 0.27, Psep = 0.01;
R2joint = 0.21, Pjoint = 0.02) after omitting chromosome 6
due to its exceptional contribution (Figure 1). This ob-
served correlation was consistent with a polygenic effect
that has been detected for other traits and diseases
[19,20]. In addition, since the estimates obtained from the
separate and joint analysis were consistent, we were
confident that the relationship between chromosomal
length and percent variation in psoriasis liability explained
were robust. We note that the largest proportion of vari-
ation in liability to psoriasis was explained by the HLA re-
gion on chromosome 6 for both the separate and joint
analysis approaches.Partition of genomic variation by minor allele frequency
We also partitioned the variation attributable to a poly-
genic effect captured by common variants into two com-
ponents defined by SNP minor allele frequency (MAF):
frequent (MAF > 0.05) or infrequent (0.01 <MAF < 0.05).
Markers with infrequent variants in the G and G + I
datasets explained 1.1% (45,769 SNPs, s.e. = 3.0%) and
3.0% (1,235,720 SNPs, s.e. = 4.0%) of the variation in li-
ability to psoriasis, respectively. Markers with frequent
variants captured greater than 30% of the phenotypic
variation in this population in both datasets (Figure 2).
It should be noted, however, that although imputation
procedures improved the coverage of infrequent vari-
ants, the proportion of uncommon SNPs was still only
9.3% and 22% in the G and G + I datasets, respectively.
Thus, any conclusive inference on the overall contribu-
tion of variants based on minor allele frequency should
be qualified by the limitations of our study with respect
to sample size and our reliance on genotyping chips and
imputation strategies.
Polygenicity and diagnostic potential
Given our estimates of h2SNP, we were interested in deter-
mining how well psoriasis cases and controls could be
distinguished on a purely genetic basis if all common
markers which contribute to h2SNP were identified [21,22].
These analyses give an indication of how useful our under-
standing of the genetic basis of psoriasis may be in terms
of genetically diagnosing the disease based on GWAS
data. These analyses also require assumptions about the
overall prevalence of psoriasis, so we considered a few dif-
ferent, yet realistic assumptions about the prevalence (i.e.,
0.1 to 0.6%), as well as the overall heritability of psoriasis
attributable a polygenic component based on our h2SNP
estimate of roughly 35% and its standard error (6.0%).
Using the genroc calculator [21] (available at: http://gump.
qimr.edu.au/genroc/) and assuming the prevalence of
psoriasis among Han Chinese is 0.47% [18], a polygenic
predictor that explains 35% of the variation in liability to
psoriasis will have an area under the receiver operating
characteristic curve (AUC) value of 0.91. This suggests
that there is a 0.91 probability of classifying a random in-
dividual with psoriasis correctly relative to a random indi-
vidual without psoriasis. We varied both the prevalence
Figure 1 The proportion of liability explained by markers on each chromosome.
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psoriasis attributable to a polygenic effect (27-41%) and
found that the AUC remained consistently high (0.88-
0.96), implying that genome-wide commonly genotyped
markers may one day be used as a robust statistical classi-
fier for psoriasis diagnosis.
Discussion
In this study we sought to shed light on the polygenic
basis of psoriasis in the Han Chinese population. Our
results suggest that more than one-third of variation in li-
ability to psoriasis could be captured by the collective
effect of common SNPs. Combined with our previous
findings in GWAS, we conclude that a substantial portionFigure 2 The proportion of liability explained by marker based on miof heritability is ‘hidden’ from standard single locus-
oriented analysis techniques in our population. This sug-
gests, however, that large-scale GWAS efforts may have
potential to recover additional common variants associ-
ated with susceptibility to psoriasis, but will likely require
much larger sample sizes due to the small effect sizes of
these loci. We also find evidence that the proportion of
variation explained by individual chromosomes is posi-
tively correlated with chromosomal length, which is also
consistent with the notion that susceptibility of psoriasis
has a polygenic basis. In addition, we found that uncom-
mon variants that were genotyped or imputed did not
substantially contribute to our estimate of h2SNP. Finally,
we have shown that the substantial polygenic basis ofnor allele frequency.
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noses of psoriasis.
Although there has been continued debate as to whether
the heritability of common diseases is mostly accounted
for by common variants with small effects or rare variants
with larger effects, there have been few definitive studies
to settle this debate. Our study demonstrates that com-
mon SNPs are likely to explain a large portion of the herit-
ability in psoriasis among Han Chinese. Given that the
reported loci in our previous GWAS explain a modest
fraction of the heritability estimated from twin studies
and our estimate of h2SNP in the present study, we be-
lieve that other common variants which did not meet
the significance threshold remain to be identified. Data
from previous studies have shown that markers identi-
fied through GWAS explain 14.3% of the total variation
in psoriasis risk. Based on calculation, a classifier which
is able to explain 15% of the variation in psoriasis risk
will have an AUC of 0.8. Thus, a purely genetic diagno-
sis of psoriasis may be within reach. However, large
sample sizes (N > 50,000) will be required to detect add-
itional markers with increasingly small effects (odds ra-
tios < 1.1) [12,23,24].
To further illustrate the important role of the collect-
ive effect of common variants each with small effect on
psoriasis, we implemented a partitioning analysis based
on minor allele frequency in our datasets. We find that
only a small fraction of phenotypic variation can be at-
tributed to SNPs with low frequent variants. However,
this may be due to the under-representation of SNPs
with low minor allele frequency on the genotyping array
and imputation strategies we used. In addition, it is ex-
pected that weaker additive genetic effects are not well
tagged by SNPs with low frequency due to weak linkage
disequilibrium with rare causal variants. Our estimate of
h2SNP was less than half of established heritability of
psoriasis in the Han Chinese population [25]. This dif-
ference can partially be attributed to imperfect linkage
disequilibrium between causal and genotyped variants,
imperfectly imputed variants, and genetic interactions,
in addition to other sources – but also notably rare vari-
ants. Thus, rare variants which are not well captured by
our approach may contribute to this difference.
We find that more than 13.0% of the liability to psoria-
sis can be explained by markers in the HLA region
alone, which is consistent with overwhelming evidence
from GWAS studies implicating variants in this region.
It is notable that chromosome 6 explained a large pro-
portion of phenotypic variation. Although this may be a
result of the high linkage disequilibrium between vari-
ants in the HLA region, this nevertheless highlights the
important role of the HLA locus in the susceptibility of
psoriasis. In addition, although several specific suscepti-
bility genes and variants in the HLA region have beenrevealed [14], future studies using sequencing approaches
may be needed to identify actual causal genes and variants
in this region. This may be important in further improving
a genetic-based diagnostic for psoriasis. Also, given that
there may be non-genetic factors contributing to psoriasis,
the inclusion of these factors in a psoriasis diagnostic
would likely improve its reliability and utility. Thus, des-
pite the fact that psoriasis seems to have a large polygenic
component that may make it difficult to identify each vari-
ant contributing to disease, there is potential for a genetic
diagnosis of using whole genome genotyping and analyses.Conclusions
We have performed a polygenic analysis of psoriasis in
Han Chinese samples. We estimated the contribution of
common variants to psoriasis phenotypic variation. Our
study suggests that substantial polygenic component has
been hidden in psoriasis, which not only has implications
for the development of genetic diagnostics and prognos-
tics for psoriasis, but also suggests that more individual
variants contributing to psoriasis may be detected if sam-
ple sizes in future association studies are increased.Competing interests
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